Dr. Christopher J. Sayed shares insights on the growing emphasis on personalized care for hidradenitis suppurativa.

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

Trial could ‘usher in a new era’ of affordable antibody therapies to protect against dangerous infectious diseases like Mers, ...

Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, ...

Type I allergy, an IgE antibody triggered hypersensitivity disease, represents a common public health problem affecting about one third of the world´s population. Upon exposure to allergens, IgE ...

Center for Cancer Diagnosis and Treatment, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province 215000, China ...

Figure 4. Humanization profile of nanobodies evaluated by AbNatiV. The bar chart comparing the computational humanization profile of the whole nanobodies (ECSbs and SR6c3) and their overall score, CDR ...

KAUST Catalysis Center (KCC), Division of Physical Sciences and Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Kingdom of Saudi Arabia ...

Researchers at Stanford have designed a dual-antibody treatment that remains effective against COVID-19 variants by targeting a less-mutable part of the virus. This breakthrough could lead to ...

nanobodies, enzymes, cytokines, various antigens, polypeptides, and plasmid DNA (pDNA) — all of which present significant opportunities for the development of next-generation therapies.

Herpes has long been known to lie dormant in the body, waiting for the right moment to strike. But new research has revealed a shocking twist—rather than waiting passively, the virus actually wakes ...

These tools allow testing of Nanobodies against new mutations of viruses like the Andes virus or COVID-19. Provided by SyndiGate Media Inc. ( Syndigate.info ...